This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Kerecis Omega3 Wound fish skin grafts for improving healing and closure of diabetic foot ulcers (DFUs).
Evidence Analysis
It is a challenge for health plans and clinicians to distill and analyze volumes of clinical evidence to determine likely clinical, financial, and risk impacts. This is what we do.Accessed through the Hayes Knowledge Center, the Evidence Analysis Solution addresses the following fundamental questions to help our clients determine coverage positions:
- Does the technology improve health outcomes?
- Are there other benefits associated with the technology?
- What harms might be associated with the technology?
- Have patient selection criteria been established for the technology?
- For which patients might the technology provide a benefit?
- Health Technology Assessments
- Evidence Analysis Research Briefs
- Evolving Evidence Review
- Clinical Research Responses
Kerecis Omega3 Wound (Kerecis) Fish Skin Grafts for Management of Burns
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Kerecis Omega3 Wound (Kerecis) fish skin grafts for treatment of burns.
Platelet-Rich Plasma for Treatment of Patellar Tendinopathy
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of platelet-rich plasma for treatment of patellar tendinopathy.
inFlow Intraurethral Valve-Pump and Activator (Vesiflo Inc.) for Bladder Drainage in Female Patients with Chronic Urinary Retention
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the inFlow Intraurethral Valve-Pump and Activator (Vesiflo Inc.) for bladder drainage in female patients with chronic urinary retention.
NovoSorb Biodegradable Temporizing Matrix (BTM) (PolyNovo Pty Ltd.) for Treatment of Diabetic Foot Ulcers
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of NovoSorb Biodegradable Temporizing Matrix (BTM) (PolyNovo Pty Ltd.) for treatment of diabetic foot ulcers (DFUs).
EyeBOX (Oculogica) as an Aid in Diagnosis of Concussion
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the EyeBOX test (Oculogica) as an aid in the diagnosis of concussion, also known as mild traumatic brain injury (mild TBI).
Vivistim Paired VNS System (MicroTransponder Inc.) for Treatment of Upper Limb Impairment Due to Stroke
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the Vivistim Paired Vagus Nerve Stimulation (VNS) System (MicroTransponder Inc.) for rehabilitation of upper extremity impairment following stroke.
Systemic Hyperbaric Oxygen Therapy for Venous Ulcers
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of systemic (chamber) hyperbaric oxygen therapy (HBOT) for the treatment of venous ulcers for improved wound closure and healing.
Percutaneous Sacroplasty for Treatment of Sacral Insufficiency Fractures Due to Causes Other Than Malignancy
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of percutaneous sacroplasty for the treatment of sacral insufficiency fractures (SIFs) in adults who primarily have an underlying cause other than malignancy.
Topical Hyperbaric Oxygen Therapy for Venous Ulcers
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of topical (local) hyperbaric oxygen therapy (HBOT) for the treatment of venous ulcers to improve wound healing.